Improving Patient Experience With Insulin Infusion Sets Practical Guidelines and Future Directions
作者： Alison B. Evert , Bruce W. Bode , Bruce A. Buckingham , Elizabeth Nardacci , Carol A. Verderese
关键词:
摘要: PurposeInsulin infusion sets (IISs) are an essential component of safe and effective insulin pump therapy. Establishing best practices for their use has been impeded by a lack formal study limited resources clinician patient education. Recent innovations in IIS science promise to change this status quo increasing awareness such problems as unexplained hyperglycemia set occlusion.MethodsIn August 2015, panel diabetologists certified diabetes educators from various disciplines was convened reconsider IIS-related complications therapy, better characterize factors affecting experience, update priorities optimizing current technologies. Actionable guidelines were provided addressing common issues, including skin reactions, site rotation changes, dislodgment the set, partial or complete blockage catheter. These issues may underlie episodes failure and/or hyperglycemia.Co...
sagepub.com
sci-hub.se 参考文章(12)
Benjamin J. Wheeler, Kristine Heels, Kim C. Donaghue, David M. Reith, Geoffrey R. Ambler, Insulin Pump–Associated Adverse Events in Children and Adolescents—A Prospective Study Diabetes Technology & Therapeutics. ,vol. 16, pp. 558- 562 ,(2014) , 10.1089/DIA.2013.0388
Parul J. Patel, Kari Benasi, Gina Ferrari, Mark G. Evans, Satya Shanmugham, Darrell M. Wilson, Bruce A. Buckingham, Randomized trial of infusion set function: steel versus teflon. Diabetes Technology & Therapeutics. ,vol. 16, pp. 15- 19 ,(2014) , 10.1089/DIA.2013.0119
H. Zisser, Quantifying the Impact of a Short-Interval Interruption of Insulin-Pump Infusion Sets on Glycemic Excursions Diabetes Care. ,vol. 31, pp. 238- 239 ,(2008) , 10.2337/DC07-1757
Arianne C. van Bon, Bruce W. Bode, Caroline Sert-Langeron, J. Hans DeVries, Guillaume Charpentier, Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technology & Therapeutics. ,vol. 13, pp. 607- 614 ,(2011) , 10.1089/DIA.2010.0224
Jay S. Skyler, Davida F. Kruger, Della Matheson, Bruce W. Brown, Stephen W. Ponder, Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment. The Diabetes Educator. ,vol. 34, pp. 327- 333 ,(2008) , 10.1177/0145721708315682
John C. Pickup, Nardos Yemane, Anna Brackenridge, Siobhan Pender, Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technology & Therapeutics. ,vol. 16, pp. 145- 149 ,(2014) , 10.1089/DIA.2013.0192
Lutz Heinemann, Lars Krinelke, Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. Journal of diabetes science and technology. ,vol. 6, pp. 954- 964 ,(2012) , 10.1177/193229681200600429
Lutz Heinemann, Eric Zijlstra, Stefan Pleus, Guido Freckmann, Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View Diabetes Care. ,vol. 38, ,(2015) , 10.2337/DC15-0817
Jill H Simmons, Vincent Chen, Kellee M Miller, Janet B McGill, Richard M Bergenstal, Robin S Goland, David M Harlan, Joseph F Largay, Elaine M Massaro, Roy W Beck, T1D Exchange Clinic Network, None, Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry Diabetes Care. ,vol. 36, pp. 3573- 3577 ,(2013) , 10.2337/DC12-2643
Lutz Heinemann, G. Alexander Fleming, John R. Petrie, Reinhard W. Holl, Richard M. Bergenstal, Anne L. Peters, Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group Diabetes Care. ,vol. 38, pp. 716- 722 ,(2015) , 10.2337/DC15-0168